U.S. Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Medical Diagnostics & Research
IDEXX Laboratories Inc (IDXX) Q2 2024 Earnings Call Transcript Highlights: Solid Organic Revenue Growth Amid Litigation Expenses
Despite a 9% EPS decline due to litigation expenses, IDEXX Laboratories Inc (IDXX) reports strong organic revenue growth and updates its full-year guidance. Aug 07, 2024
GuruFocus Research Oil & Gas
Diamondback Energy Inc (FANG) Q2 2024 Earnings Call Transcript Highlights: Strong Financial Performance and Operational Efficiencies
Diamondback Energy Inc (FANG) reports robust revenue and net income, with significant gains in drilling and completion efficiencies. Aug 07, 2024
GuruFocus Research REITs
Angel Oak Mortgage REIT Inc (AOMR) Q2 2024 Earnings Call Transcript Highlights: Strong Net Interest Income Growth Amidst GAAP Net Loss
Angel Oak Mortgage REIT Inc (AOMR) reports a fourth consecutive quarter of net interest income growth despite a GAAP net loss and decreased book values. Aug 07, 2024
GuruFocus Research Transportation
GXO Logistics Inc (GXO) Q2 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic Wins Amid Market Uncertainty
GXO Logistics Inc (GXO) reports robust growth and strategic advancements despite challenges in core volumes and market conditions. Aug 07, 2024
GuruFocus Research Medical Devices & Instruments
Baxter International Inc (BAX) Q2 2024 Earnings Call Transcript Highlights: Strong Performance and Revised Guidance
Revenue and EPS exceed expectations, with broad-based sales growth and strategic investments driving future outlook. Aug 07, 2024 ★★★★★
GuruFocus Research Drug Manufacturers
Trulieve Cannabis Corp (TCNNF) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Improved Margins
Trulieve Cannabis Corp (TCNNF) reports a third consecutive quarter of top-line growth and margin expansion despite seasonal headwinds. Aug 07, 2024
GuruFocus Research Healthcare Providers & Services
Surgery Partners Inc (SGRY) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Expansion
Key financial metrics show robust performance, with significant growth in net revenue, adjusted EBITDA, and physician recruitment. Aug 07, 2024
GuruFocus Research Travel & Leisure
Planet Fitness Inc (PLNT) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth Amidst Operational Challenges
Planet Fitness Inc (PLNT) reports robust revenue and adjusted EBITDA growth, despite increased operational expenses and slower store openings. Aug 07, 2024
GuruFocus Research Medical Devices & Instruments
Orthofix Medical Inc (OFIX) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Positive Momentum
Orthofix Medical Inc (OFIX) reports 6% year-over-year revenue growth and raises full-year guidance amid robust performance. Aug 07, 2024
GuruFocus Research Biotechnology
Rhythm Pharmaceuticals Inc (RYTM) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Key Regulatory Milestones
Rhythm Pharmaceuticals Inc (RYTM) reports a 12% revenue increase and significant progress in regulatory approvals and clinical trials. Aug 07, 2024